VIDEO

FindCenter AddIcon

MINDSET Lecture Series: Natalie Ginsberg, MSW

By Natalie Ginsberg — 2021

Natalie Ginsberg, MSW, discusses ayahuasca and the healing potential of psychedelics for intergenerational trauma in the Palestinian-Israeli conflict.

58:39 min

A Brief History of Psychedelic Psychiatry

In the 1950s a group of pioneering psychiatrists showed that hallucinogenic drugs had therapeutic potential, but the research was halted as part of the backlash against the hippy counterculture.

Article
Mo Costandi
2014
FindCenter AddIcon

Integration, Rippling

In the deep space of the psychedelic experience exists a teaching on unity principle and belonging with the earth.

Article
Francoise Bourzant
2020
FindCenter AddIcon

The Cost of Exclusion in Psychedelic Research

In the last two decades, researchers have started to reexamine psychedelics for their therapeutic potential. Though initial results seem promising, the research has a significant shortcoming: the lack of racial and ethnic diversity among research teams and study participants.

Article
Xinyuan Chen, Mackenzie Bullard, Christy Duan, Jamilah R. George, Terence Ching, Stephanie Kilpatrick, Jordan Sloshower, Monnica Williams
2020
FindCenter AddIcon

Psychedelic Psychotherapy Is Coming: Who Will Be Included?

A new study finds widespread exclusion of minorities in psychedelic research.

Article
Monnica T. Williams
2018
FindCenter AddIcon

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

Article
Steph Yin
2020
FindCenter AddIcon

Who Will Benefit From Psychedelic Medicine?

These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.

Article
Whitney Joiner
2020
FindCenter AddIcon

Seismic Sisters: Fighting Stigma of Psychedelics with Science - An Interview with Natalie Ginsberg, Policy and Advocacy Director at Multidisciplinary Association for Psychedelic Studies

Society has started to become more accepting of our work and MAPS’ goal of mainstreaming psychedelic medicine seems closer than ever to being achieved,” explains MAPS Policy and Advocacy Director Natalie Ginsberg, M.S.W., in an interview with Jessica Semaan of Seismic Sisters.

Article
Jessica Semaan
2020
FindCenter AddIcon

5 Women in Psychedelics You Should Know About

Badass women making waves in the psychedelic movement, from research to drug policy reform.

Article
Michelle Janikian
2019
FindCenter AddIcon

Psilocybin Therapy May Work as Well as Common Antidepressant

The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.

Article
Zoe Cormier
2021
FindCenter AddIcon

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy.

Article
Andrew Jacobs
2021
FindCenter AddIcon

EXPLORE TOPIC

Psychedelic-Assisted Therapy